[Type III hyperlipoproteinemia in idiopathic hemochromatosis].
We studied a 60-year-old male with idiopathic (primary) hemochromatosis and type III hyperlipoproteinemia. Periodical phlebotomy therapy could favourably influence the disease of iron metabolism as well as the familial lipoprotein disorder in addition to fenofibrate treatment. Idiopathic hemochromatosis as aggravating cause of type III hyperlipoproteinemia has not been reported yet.
Feussner
G
G
Abteilung Innere Medizin I, Universität Heidelberg.
Ziegler
R
R
D001815:Bloodletting; D003131:Combined Modality Therapy; D011345:Fenofibrate / Q000008:administration & dosage; D006432:Hemochromatosis / Q000097:blood* / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D006952:Hyperlipoproteinemia Type III / Q000097:blood* / Q000175:diagnosis / Q000628:therapy; D008055:Lipids / Q000097:blood*; D008103:Liver Cirrhosis / Q000097:blood*; D008297:Male; D008875:Middle Aged
D008055:Lipids; D011345:Fenofibrate
Typ III Hyperlipoproteinämie bei idiopathischer Hämochromatose.